Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suramin + ADT in Metastatic Prostate Cancer
NCT00002881Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Oct 1996
- Primary completion
- Apr 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of suramin in Metastatic Prostate Cancer (mPC), sponsored by Eastern Cooperative Oncology Group. Started Oct 1996; status: completed.
02
Drugs
suramin
03
Conditions
Metastatic Prostate Cancer (mPC)
Beyond the preview
Go deeper on NCT00002881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002881.